Cross-talk among the β-catenin, ERK/MAPK, and PI3K/Akt signaling pathways has been detected in many cancers, with simultaneous inhibition of apoptosis and blocking of differentiation [7,8]. The gene discussed is AKT1; the disease is cancer.